Comparative risk of serious hypoglycemia with oral antidiabetic monotherapy: A retrospective cohort study
Confounding Factors (Epidemiology)
Data Interpretation, Statistical
Outcome Assessment (Health Care)
Sulfonylureas were associated with the highest rates of serious hypoglycemia. Among all study drugs, the highest rate was seen with glyburide. Pioglitazone was associated with a lower adjusted hazard for serious hypoglycemia vs metformin, while rosiglitazone and nateglinide had hazards similar to that of metformin.